This “Boring” Company Has Massive 2019 Catalysts That Could Send the Stock Soaring

Jamieson Wellness Inc. (TSX:JWEL) is a wonderful business at a wonderful price.

| More on:
Gold king in chess game face with the another silver team on black background (Concept for company strategy, business victory or decision)

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In terms of businesses, it really doesn’t get more boring than Jamieson Wellness (TSX:JWEL) and its business within the vitamins, minerals, and supplements (VMS) space. That’s a huge reason why the company’s IPO was fairly quiet a few years back, with many Canadian investors to this day who remain unaware that Canada’s “ruler of the medicine cabinet” has a publicly traded stock on the TSX.

For disciples of Warren Buffett (Buffettarians), we know that boring is beautiful. And Jamieson could be seen as a staple business that the Oracle of Omaha himself could own if he’d shown a greater affinity for Canadian stocks.

The VMS business is very competitive, so Jamieson needs a distinct advantage to rise above the pack to be what Buffett would deem as a “wonderful business.”

While it may seem like any startup firm or shady multi-level marketer (MLM) down the street can make their own vitamin overnight, I believe no new entrant will ever be able to compete with the likes of Jamieson and its iconic brand that’s been built over the course of a century. Jamieson has been “ruling” Canadian medicine cabinets for generations, and that’s brand power that money really can’t buy.

The company has maintained a sound reputation for a ridiculously lengthy amount of time, and as a result, Jamieson is not only a household name in Canada; it’s a top foreign brand in the booming Chinese market — a huge growth market for Jamieson moving forward.

Why?

It all comes down to trust. In a time where competing firms are adding “filler” to their products to lower expenses and drive up gross margins, consumers need a name they can rely on when it comes to something as critical as their health. If you’ve got a vitamin D deficiency, as many Canadians have, you want to be sure you’re getting the quantities of vitamin that’s on the label, and not a fraction of it.

Jamieson bottles up a lot more than what’s on the label.

You’re getting the assurance of impeccable quality, and a higher degree of precision when it comes to the labelled quantities. It’s the trust that in the brand that allows the green-capped bottles to command a hefty premium over competing products. And as Jamieson continues to launch new products while moving into the red-hot Chinese market, Jamieson stock could be ready to take off in 2019.

Core domestic products clocked in an impressive 10.2% in year-over-year growth for the third quarter. Marketing campaigns have clearly allowed Jamieson to take share over its competitors. And with more Canadians on the Jamieson bandwagon, new product launches could be like rocket fuel for the company’s top line moving forward. Add product launches in China into the equation, and I think Jamieson could easily surge 50% by year end.

The stock trades at $21 and change at the time of writing, and with the stock flat-lining since the “malnourished” third quarter, I think now is an opportune time to pounce on shares before they correct upwards.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »